GSK

Q: What is the price of GlaxoSmithKline (GSK) today?

The price of GlaxoSmithKline (GSK) today is $ 46.99, with return of 45.94% compared to the last year. The price of GlaxoSmithKline (GSK) started the year trading around $ 33.82 and today it is at $ 46.99. Follow the real-time price chart, the historical price of GlaxoSmithKline (GSK) and international markets.

Q: When does GlaxoSmithKline (GSK) pay dividends?

GlaxoSmithKline (GSK) distributed dividends in the last year,in the months of January, April, July and October totaling $ 1.65. The Dividend Yield for the last 12 months is 3.52%.

Q: Is GlaxoSmithKline (GSK) worth it?

Currently, GlaxoSmithKline (GSK) is priced at $ 46.99, with a P/E of 12.93%, representando um desvio de 1,168% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 45.94 in its price and distributed $ 1.65 in dividends, resulting in a Dividend Yield of 3.52%. The total shareholder return was 45.94%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy GlaxoSmithKline (GSK) stock?

Investing in stocks of GlaxoSmithKline (GSK) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of GlaxoSmithKline (GSK) yield today?

The yield of GlaxoSmithKline (GSK) was 9.61% in the last month, 45.94% in the last year and 101.20% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 1.65 in dividends, a Dividend Yield of 3.52%.If you wanted to buy 100 stocks of GlaxoSmithKline (GSK) today, the total investment would be $ 4,699.00, based on the current price of $ 46.99.If past performance were to repeat, the return on your investment would be:In 1 year: $ 6,857.72In 5 years: $ 9,454.39In 10 years: $ 12,203.30It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

GlaxoSmithKline PLC

Price

$ 46.99

return (12m)

45.94%

p/e

12.93

p/bv

4.43

DIVIDEND YIELD

3.52%

price GSK

BVMF

GSK

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, you would now have

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of GSK

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

9.61%

3 months

20.30%

1 year

45.94%

2 years

44.37%

5 years

101.20%

10 years

159.70%

Fundamentals GSK

review the fundamentals of GlaxoSmithKline shares

P/E

12.93

Sector: -2.16 Industry: -4.35

P/SALES RATIO (PSR)

2.23

Sector: 1.99 Industry: 2.82

P/BV

4.43

Sector: 2.12 Industry: 1.99

DIVIDEND YIELD (DY)

3.52%

Sector: - Industry: -

ROA

8.81%

Sector: -26.99% Industry: -53.23%

ROE

34.29%

Sector: -30.03% Industry: -43.96%

ROIC

18.95%

Sector: -414.93% Industry: -472.50%

NET MARGIN

17.23%

Sector: -27.97% Industry: -32.87%

GROSS MARGIN

72.32%

Sector: 44.10% Industry: 45.08%

OPERATING MARGIN

23.59%

Sector: -24.33% Industry: -29.79%

P/EBITDA

6.32

Sector: -0.32 Industry: -3.32

P/EBIT

9.24

Sector: -2.46 Industry: -4.39

P/ASSET

1.14

Sector: 1.19 Industry: 1.35

BVPS

10.55

Sector: 3.38 Industry: 1.66

EPS

3.62

Sector: -0.89 Industry: -1.28

EQUITY RATIO

0.26

Sector: 0.43 Industry: 0.46

CAGR REVENUE 5 YEARS

6.69%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.03%

Sector: - Industry: -

FAIR VALUE OF GlaxoSmithKline ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 46.99

Fair Value

$ 0.00

Upside Return potential.

-37.62%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals GSK

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	51.55	39.80	77.20%	0.55%	$ 949.16 B	30.99%
ISRG	72.99	11.76	16.12%	0.00%	$ 200.49 B	28.58%
TMO	33.80	4.34	12.84%	0.29%	$ 222.07 B	15.02%
SNY	10.79	1.50	13.90%	4.46%	$ 121.64 B	14.83%
MDT	27.23	0.00	0.00%	2.79%	$ 129.74 B	13.71%
NVS	17.04	5.48	32.16%	3.04%	$ 245.20 B	25.53%
ABT	15.34	4.18	27.26%	1.89%	$ 214.39 B	31.88%
CVS	211.13	1.35	0.64%	3.41%	$ 99.02 B	0.12%
BSX	51.42	0.00	0.00%	0.00%	$ 143.58 B	14.43%
TMDX	48.51	12.53	25.84%	0.00%	$ 4.45 B	16.20%
HCA	18.03	-52.99	-293.84%	0.57%	$ 114.40 B	8.53%
IDXX	56.52	37.20	65.81%	0.00%	$ 58.07 B	24.65%
INMD	5.92	1.36	22.89%	0.00%	$ 885.78 M	41.04%
DHR	46.15	3.17	6.86%	0.54%	$ 161.67 B	14.43%
FMS	16.76	0.84	5.00%	3.36%	$ 13.67 B	3.73%
RMD	25.40	5.97	23.49%	0.88%	$ 36.52 B	27.35%
PHG	115.12	2.09	1.81%	3.25%	$ 25.92 B	1.14%
HUM	21.11	1.47	6.95%	1.56%	$ 27.25 B	1.02%
SYK	47.80	6.46	13.51%	0.91%	$ 140.68 B	12.07%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

GSK Historical Dividends

current DY: 3.52%

5-year average DY: 6.22%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	11/14/2025	01/08/2026	0,40960000
Dividend	08/15/2025	10/09/2025	0,42810000
Dividend	05/16/2025	07/10/2025	0,42910000
Dividend	02/21/2025	04/10/2025	0,40060000
Dividend	11/15/2024	01/09/2025	0,38900000
Dividend	08/16/2024	10/10/2024	0,38570000
Dividend	05/17/2024	07/11/2024	0,37620000
Dividend	02/23/2024	04/11/2024	0,40610000
Dividend	11/17/2023	01/11/2024	0,33980000
Dividend	08/18/2023	10/12/2023	0,36130000
Dividend	05/19/2023	07/13/2023	0,34750000
Dividend	02/24/2023	04/13/2023	0,34040000
Dividend	11/18/2022	01/12/2023	0,31710000
Dividend	08/19/2022	10/06/2022	0,39080000
Dividend	05/20/2022	07/01/2022	0,34960000
Dividend	02/25/2022	04/07/2022	0,62210000
Dividend	11/19/2021	01/13/2022	0,52340000
Dividend	08/20/2021	10/07/2021	0,53010000
Dividend	05/21/2021	07/08/2021	0,52700000
Dividend	02/19/2021	04/08/2021	0,63670000
Dividend	11/13/2020	01/14/2021	0,49600000
Dividend	08/14/2020	10/08/2020	0,49290000
Dividend	05/15/2020	07/09/2020	0,47390000
Dividend	02/21/2020	04/09/2020	0,59900000
Dividend	11/15/2019	01/09/2020	0,48900000
Dividend	08/09/2019	10/10/2019	0,46580000
Dividend	05/17/2019	07/11/2019	0,49530000
Dividend	02/22/2019	04/11/2019	0,60170000
Dividend	11/16/2018	01/10/2019	0,48380000
Dividend	08/10/2018	10/11/2018	0,50110000
Dividend	05/11/2018	07/12/2018	0,53000000
Dividend	02/23/2018	04/12/2018	0,63800000
Dividend	11/10/2017	01/11/2018	0,50400000
Dividend	08/11/2017	10/12/2017	0,50100000
Dividend	05/12/2017	07/13/2017	0,49040000
Dividend	02/24/2017	04/13/2017	0,57120000
Dividend	11/04/2016	01/12/2017	0,46210000
Dividend	08/12/2016	10/13/2016	0,49900000
Dividend	05/13/2016	07/14/2016	0,55400000
Dividend	02/19/2016	04/14/2016	1,25200000
Dividend	11/13/2015	01/14/2016	0,58200000
Dividend	08/14/2015	10/01/2015	0,59300000
Dividend	05/15/2015	07/09/2015	0,57790000
Dividend	02/20/2015	04/09/2015	0,68540000
Dividend	11/07/2014	01/08/2015	0,60440000
Dividend	08/08/2014	10/02/2014	0,63910000
Dividend	05/16/2014	07/10/2014	0,63100000
Dividend	02/21/2014	04/10/2014	0,75000000
Dividend	11/15/2013	01/09/2014	0,60740000
Dividend	08/09/2013	10/03/2013	0,54540000
Dividend	05/10/2013	07/11/2013	0,54250000
Dividend	02/22/2013	04/11/2013	0,67980000
Dividend	11/16/2012	01/03/2013	0,57080000
Dividend	08/10/2012	10/04/2012	0,52050000
Dividend	05/11/2012	07/05/2012	0,54140000
Dividend	02/17/2012	04/12/2012	0,82100000
Dividend	11/04/2011	01/05/2012	0,53350000
Dividend	08/05/2011	10/06/2011	0,51200000
Dividend	05/06/2011	07/07/2011	0,51710000
Dividend	02/11/2011	04/07/2011	0,61500000
Dividend	10/29/2010	01/06/2011	0,49850000
Dividend	07/30/2010	10/07/2010	0,44920000
Dividend	05/07/2010	07/08/2010	0,45230000
Dividend	02/12/2010	04/08/2010	0,57400000
Dividend	11/06/2009	01/07/2010	0,48140000
Dividend	07/31/2009	10/08/2009	0,45290000
Dividend	05/01/2009	07/09/2009	0,40210000
Dividend	02/13/2009	04/09/2009	0,48590000
Dividend	10/31/2008	01/08/2009	0,46650000
Dividend	08/01/2008	10/09/2008	0,51000000
Dividend	05/02/2008	07/10/2008	0,50950000
Dividend	02/15/2008	04/10/2008	0,62700000
Dividend	11/02/2007	01/10/2008	0,52320000
Dividend	08/03/2007	10/11/2007	0,48600000
Dividend	05/04/2007	07/12/2007	0,47220000
Dividend	02/16/2007	04/12/2007	0,55200000
Dividend	11/03/2006	01/04/2007	0,44260000
Dividend	08/04/2006	10/05/2006	0,39920000
Dividend	05/12/2006	07/06/2006	0,38630000
Dividend	02/17/2006	04/06/2006	0,47890000
Dividend	11/04/2005	01/05/2006	0,34900000
Dividend	08/05/2005	10/06/2005	0,34170000
Dividend	05/13/2005	07/07/2005	0,37340000
Dividend	02/18/2005	04/07/2005	0,43660000
Dividend	11/05/2004	01/06/2005	0,35880000
Dividend	08/06/2004	09/30/2004	0,35950000
Dividend	05/14/2004	07/01/2004	0,34660000
Dividend	02/20/2004	04/15/2004	0,51080000
Dividend	10/31/2003	01/06/2004	0,29490000
Dividend	08/01/2003	10/02/2003	0,28130000
Dividend	05/09/2003	07/03/2003	0,31700000
Dividend	02/21/2003	04/17/2003	0,45700000
Dividend	11/01/2002	01/03/2003	0,30260000
Dividend	08/02/2002	10/03/2002	0,30590000
Dividend	05/03/2002	07/05/2002	0,55500000
Dividend	02/22/2002	04/18/2002	0,71500000
Dividend	11/02/2001	01/03/2002	0,27930000
Dividend	08/03/2001	10/04/2001	0,27790000
Dividend	05/04/2001	07/05/2001	0,28230000
Dividend	12/26/2000	04/27/2001	0,74200000
Dividend	08/11/2000	10/26/2000	0,50200000
Dividend	03/03/2000	06/05/2000	0,78500000
Dividend	08/13/1999	10/12/1999	0,53970000
Dividend	03/05/1999	06/01/1999	0,59500000
Dividend	08/14/1998	10/13/1998	0,49980000
Dividend	03/06/1998	06/01/1998	0,65200000
Dividend	08/15/1997	12/02/1997	0,49100000
Dividend	03/21/1997	05/30/1997	0,72700000
Dividend	08/20/1996	10/11/1996	0,58400000
Dividend	03/26/1996	05/30/1996	0,58000000
Dividend	09/26/1995	11/02/1995	0,77400000
Dividend	03/02/1995	04/20/1995	0,38500000

ABOUT THE COMPANY GlaxoSmithKline

GlaxoSmithKline PLC

Average user rating I10

5.0 (66 people)

United States

26 years

Founded: 1999

1987

Time since IPO - 38 years

90.090

Employees

The Company GlaxoSmithKline PLC (United States), is listed on NYSE with a market cap of $ 94.37 Billions, having an equity of $ 21.29 Billions.

With a total of 90.090 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 42.36 Billions, which generated a profit in the amount of $ 7.30 Billions.

As for its main indicators, the Company has a P/E ratio of 12.93, a P/BV ratio of 4.43 and in the last 12 months the dividend yield of GSK was at 3.52%.

The Company is traded internationally through the ticker GSK.

Market cap

$ 94.37 Billions

Equity

$ 21.29 Billions

US$ 21,286,490,000.00

Assets

$ 82.89 Billions

US$ 82,890,540,000.00

Total Shares Outstanding

2.02 Billions

2,017,000,000

Average Daily Trading Volume

$ 5.49 Millions

US$ 5,493,362.00

Sector

Health

Industry

Pharmaceutical Products

GSK

GSK revenue and profits

Financial Results GSK

DRAG THE FRAME TO SEE MORE DATA

GSK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 77.90 35,21% (12M)

P/E

211.13

3.41%

ROE

0.64%

P/BV

1.35

CI - Cigna

$ 271.47 --16,47% (12M)

P/E

12.03

2.13%

ROE

14.63%

P/BV

1.76

CNC - Centene

$ 38.17 --37,86% (12M)

P/E

-3.39

0.00%

ROE

-25.12%

P/BV

0.85

HUM - Humana

$ 229.20 --23,29% (12M)

P/E

21.11

1.56%

ROE

6.95%

P/BV

1.47

SNY - Sanofi

$ 49.15 6,16% (12M)

P/E

10.79

4.46%

ROE

13.90%

P/BV

1.50

HCA - HCA Healthcare

$ 501.04 53,80% (12M)

P/E

18.03

0.57%

ROE

-293.84%

P/BV

-52.99

LLY - Eli Lilly

$ 1,070.16 36,82% (12M)

P/E

51.55

0.55%

ROE

77.20%

P/BV

39.80

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 77.90 35,21% (12 M)

P/L

211.13

3.41%

ROE

0.64%

P/VP

1.35

CI - Cigna

$ 271.47 --16,47% (12 M)

P/L

12.03

2.13%

ROE

14.63%

P/VP

1.76

CNC - Centene

$ 38.17 --37,86% (12 M)

P/L

-3.39

0.00%

ROE

-25.12%

P/VP

0.85

HUM - Humana

$ 229.20 --23,29% (12 M)

P/L

21.11

1.56%

ROE

6.95%

P/VP

1.47

SNY - Sanofi

$ 49.15 6,16% (12 M)

P/L

10.79

4.46%

ROE

13.90%

P/VP

1.50

HCA - HCA Healthcare

$ 501.04 53,80% (12 M)

P/L

18.03

0.57%

ROE

-293.84%

P/VP

-52.99

LLY - Eli Lilly

$ 1,070.16 36,82% (12 M)

P/L

51.55

0.55%

ROE

77.20%

P/VP

39.80

Frequently Asked Questions

What is the price of GlaxoSmithKline (GSK) today?

The price of GlaxoSmithKline (GSK) today is $ 46.99, with return of 45.94% compared to the last year. The price of GlaxoSmithKline (GSK) started the year trading around $ 33.82 and today it is at $ 46.99. Follow the real-time price chart, the historical price of GlaxoSmithKline (GSK) and international markets.

When does GlaxoSmithKline (GSK) pay dividends?

GlaxoSmithKline (GSK) distributed dividends in the last year,in the months of January, April, July and October totaling $ 1.65. The Dividend Yield for the last 12 months is 3.52%.

Is GlaxoSmithKline (GSK) worth it?

Currently, GlaxoSmithKline (GSK) is priced at $ 46.99, with a P/E of 12.93%, representando um desvio de 1,168% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 45.94 in its price and distributed $ 1.65 in dividends, resulting in a Dividend Yield of 3.52%. The total shareholder return was 45.94%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy GlaxoSmithKline (GSK) stock?

Investing in stocks of GlaxoSmithKline (GSK) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of GlaxoSmithKline (GSK) yield today?

The yield of GlaxoSmithKline (GSK) was 9.61% in the last month, 45.94% in the last year and 101.20% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 1.65 in dividends, a Dividend Yield of 3.52%.

If you wanted to buy 100 stocks of GlaxoSmithKline (GSK) today, the total investment would be $ 4,699.00, based on the current price of $ 46.99.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 6,857.72
In 5 years: $ 9,454.39
In 10 years: $ 12,203.30

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

GSK

GlaxoSmithKline PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of GSK

review the fundamentals of GlaxoSmithKline shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 3.52%

5-year average DY: 6.22%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY GlaxoSmithKline

GlaxoSmithKline PLC

United States

26 years

1987

90.090

PROFIT X PRICE GSK

Financial Results GSK

GSK cash flow

asset growth - GSK

GSK balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions